Raising The Bar For Anticoagulants? Warfarin Genotype Results Announced
This article was originally published in The Gray Sheet
Executive Summary
Results of a prospective observational study conducted by the pharmacy benefit manager Medco and the Mayo Clinic link more precise warfarin dosing through genotyping to a 30% reduction in hospitalization rates from any cause within six months of starting the drug